Calamos Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4M | Hold |
|
|||||
|
2025
Q1 | $22.2M | Buy |
|
|||||
|
2024
Q4 | $18.2M | Hold |
|
|||||
|
2024
Q3 | $21M | Sell |
|
|||||
|
2024
Q2 | $21.8M | Sell |
|
|||||
|
2024
Q1 | $20.1M | Sell |
|
|||||
|
2023
Q4 | $28.1M | Sell |
|
|||||
|
2023
Q3 | $24.4M | Hold |
|
|||||
|
2023
Q2 | $24.7M | Sell |
|
|||||
|
2023
Q1 | $25.7M | Sell |
|
|||||
|
2022
Q4 | $26.5M | Sell |
|
|||||
|
2022
Q3 | $31.2M | Buy |
|
|||||
|
2022
Q2 | $30.4M | Buy |
|
|||||
|
2022
Q1 | $27.4M | Buy |
|
|||||
|
2021
Q4 | $20M | Sell |
|
|||||
|
2021
Q3 | $20.1M | Sell |
|
|||||
|
2021
Q2 | $25.8M | Sell |
|
|||||
|
2021
Q1 | $42.8M | Buy |
|
|||||
|
2020
Q4 | $33.6M | Sell |
|
|||||
|
2020
Q3 | $39.8M | Sell |
|
|||||
|
2020
Q2 | $49.9M | Buy |
|
|||||
|
2020
Q1 | $27.3M | Buy |
|
|||||
|
2019
Q4 | $9.14M | Sell |
|
|||||
|
2019
Q3 | $7.19M | Buy |
|
|||||
|
2019
Q2 | $7.11M | Buy |
|
|||||
|
2019
Q1 | $6.78M | Buy |
|
|||||
|
2018
Q4 | $6.04M | Buy |
|
|||||
|
2018
Q3 | $5.97M | Sell |
|
|||||
|
2018
Q2 | $5.8M | Buy |
|
|||||
|
2018
Q1 | $4.91M | Buy |
|
|||||
|
2017
Q4 | $4.3M | Sell |
|
|||||
|
2017
Q3 | $4.44M | Buy |
|
|||||
|
2017
Q2 | $3.63M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $3.21M | Buy |
|